Regeneron Pharmaceuticals, Inc.REGNNASDAQ
LOADING
|||
Enterprise value to sales ratio
| Period | Value | Change |
|---|---|---|
| 2024 | 5.43 | -24.0% |
| 2023 | 7.14 | +13.1% |
| 2022 | 6.31 | +52.5% |
| 2021 | 4.14 | -32.9% |
| 2020 | 6.18 | +1.0% |
| 2019 | 6.11 | -2.6% |
| 2018 | 6.28 | -15.2% |
| 2017 | 7.40 | -15.6% |
| 2016 | 8.77 | -42.1% |
| 2015 | 15.14 | - |